Evaluation of efficacy and safety of sequential antibody drug conjugates (ADCs) in human epidermal growth factor 2 (HER2)-negative metastatic breast cancerSara Nezirevic, Heather M. Moore, Susan Dent et al.|Breast Cancer Research and Treatment|2025Cited by 3